
PMC:7417114 / 55846-55995
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T272","span":{"begin":7,"end":14},"obj":"Body_part"},{"id":"T273","span":{"begin":100,"end":106},"obj":"Body_part"},{"id":"T274","span":{"begin":107,"end":115},"obj":"Body_part"}],"attributes":[{"id":"A272","pred":"fma_id","subj":"T272","obj":"http://purl.org/sig/ont/fma/fma85272"},{"id":"A273","pred":"fma_id","subj":"T273","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A274","pred":"fma_id","subj":"T274","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"125 mg capsule orally once daily for 21 days followed by one week drug abstinence;\nbinding to human plasma proteins accounts=85% of administered dose"}
LitCovid-PD-UBERON
{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T83","span":{"begin":7,"end":14},"obj":"Body_part"}],"attributes":[{"id":"A83","pred":"uberon_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/UBERON_0003893"}],"text":"125 mg capsule orally once daily for 21 days followed by one week drug abstinence;\nbinding to human plasma proteins accounts=85% of administered dose"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T624","span":{"begin":94,"end":99},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T625","span":{"begin":100,"end":106},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"125 mg capsule orally once daily for 21 days followed by one week drug abstinence;\nbinding to human plasma proteins accounts=85% of administered dose"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T49","span":{"begin":66,"end":70},"obj":"Chemical"},{"id":"T43402","span":{"begin":107,"end":115},"obj":"Chemical"}],"attributes":[{"id":"A17624","pred":"chebi_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A71189","pred":"chebi_id","subj":"T43402","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"125 mg capsule orally once daily for 21 days followed by one week drug abstinence;\nbinding to human plasma proteins accounts=85% of administered dose"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1581","span":{"begin":94,"end":99},"obj":"Species"}],"attributes":[{"id":"A1581","pred":"tao:has_database_id","subj":"1581","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"125 mg capsule orally once daily for 21 days followed by one week drug abstinence;\nbinding to human plasma proteins accounts=85% of administered dose"}